Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 80425-0111

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 80425-0111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Dr 20mg Capsules Qty 30 Ndc 80425 0111

Label for Esomeprazole Magnesium DR 20 mg delayed-release capsules, package of 30, labeled by Advanced Rx Pharmacy of Tennessee, LLC. The label references a comparison to Nexium and includes the product NDC 80425-0111-01.*

FDA Label Image

Esomeprazole Magnesium Dr 20mg Capsules Qty 60 Ndc 80425 0111

Label for Esomeprazole Magnesium DR 20 mg delayed-release capsules, package of 60, labeled by Advanced Rx Pharmacy of Tennessee, LLC. The label includes a QR code, barcode, lot number, and storage information (20°-25°C). It references NEXIUM for comparison and shows source NDC and manufacturer Aurobindo Pharma.*

FDA Label Image

Fig 2

A line graph showing percent maintained over 6 months for Esomeprazole Magnesium at doses of 40 mg, 20 mg, 10 mg, and placebo. The y-axis represents percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6 with scheduled visits marked as 'S'. Higher doses show higher maintenance percentages compared to placebo over time.*

FDA Label Image

Fig 3

A line graph depicting the percentage maintained over a 6-month period for subjects taking Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and placebo. The x-axis shows months with scheduled visits marked, and the y-axis displays percent maintained from 0 to 100%. Different symbols represent each group, with higher doses showing better maintenance over time compared to placebo.*

FDA Label Image

Fig 4

A line graph showing the percent of patients symptom-free over 28 diary days for esomeprazole magnesium delayed-release capsules at 20 mg and 40 mg doses compared to placebo. The y-axis represents the percent of patients symptom-free, ranging from 0 to 100, and the x-axis represents diary days from 0 to 28, with three lines distinguishing the three groups.*

FDA Label Image

Fig 5

A line chart showing the percent of patients symptom-free over 28 diary days comparing Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The chart plots higher symptom-free percentages for both dosages of Esomeprazole compared to placebo throughout the period.*

FDA Label Image

Structure

Chemical structure of esomeprazole magnesium dihydrate, depicting its molecular components including magnesium cations and water of hydration (2H2O). The structure shows the two organic ligand components complexed with Mg2+ ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.